ROCKET PAIN RELIEF TRIAL
The PAH anaesthetic and broader perioperative team were able to celebrate their significant role in the trial on World Anaesthesia Day, October 17, which celebrates the first demonstration of ether anaesthesia one of most significant events in the history of medicine. The Australian National Health and Medical Research Council (NHMRC) funded trial under principal investigator Professor Philip Peyton at the University of Melbourne and Austin Health will measure chronic post-surgical pain at 12 months. If your pain level increases even after taking any medications recommended by. Find professional grade pain therapy systems & devices that can help relieve muscle tension, back pain, mensuration pain & more at comfort of your home. The types of surgery are likely to include open inguinal herniorraphy, non-cardiac thoracic surgery, including mastectomy, breast reconstruction surgery and VATS, and major orthopaedic surgery (hip, knee and shoulder arthroplasty and spinal surgery). You may feel pressure and discomfort after the placement of the RAPID RHINO pack.
ROCKET PAIN RELIEF SKIN
The study targets patients undergoing elective abdominal and orthopaedic surgery involving a skin incision at least 8 cm in length, to test the hypothesis that intravenous ketamine given prior to and following surgical incision for up to three days, reduces the incidence of chronic post-surgical pain at 12 months. This has been a team effort including the research team, surgeons, anaesthetists, pain team, ward nurses, pharmacists, and recovery nurses,” Dr Highton said. “The tremendous team effort from PA Hospital with this trial means we are one of the leading centres, recruiting our 180th patient in mid-October.
The purpose of the trial is to manage chronic pain which is a major disabling complication following surgery with up to 50 per cent of patients likely to experience chronic pain a year following surgery.Ī/Director of Anaesthesia at PA Hospital, Associate Professor David Highton said the ROCKet trial is two thirds of the way through recruitment with 3142 participants randomised at 36 active sites so far in Australia, Hong Kong and New Zealand. Princess Alexandra Hospital is now one of the largest recruiters to the international multicentre Anaesthetic ROCKet trial which examines the role of Ketamine, a strong pain relief drug, to cure chronic pain following surgery.
0 kommentar(er)
